Using Dexmedetomidine to Reduce Anesthetic Needs in Eye Surgery
Dexmedetomidine As an Effective Drug in Reducing Anesthetic Requirements in Patients Undergoing External Dacrocystorhinostomy, a Randomized Controlled Study
This study is testing if using a sedative called Dexmedetomidine can help patients having eye surgery need less anesthesia and feel more comfortable during and after the procedure.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 16 Years to 75 Years |
| Sex | All |
| Sponsor | Research Institute of Ophthalmology, Egypt Academic / other |
| Locations | 1 site (Giza) |
| Trial ID | NCT06808295 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Dexmedetomidine, a sedative, in reducing the anesthetic requirements for patients undergoing external dacrocystorhinostomy (DCR) surgery. It compares the hemodynamic stability and postoperative recovery of patients receiving Dexmedetomidine as preoperative sedation against those receiving traditional anesthesia techniques. The goal is to determine if Dexmedetomidine can enhance patient comfort and reduce opioid consumption during and after the procedure.
Who should consider this trial
Good fit: Ideal candidates are adults aged 16 to 75 with an ASA classification of I-III who are scheduled for external dacrocystorhinostomy.
Not a fit: Patients outside the age range of 16 to 75 or those with an ASA classification greater than III may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved recovery times and reduced opioid use for patients undergoing eye surgery.
How similar studies have performed: While the use of Dexmedetomidine in various surgical settings has shown promise, this specific application in DCR surgery is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: patients of both sexes 16 years to 75 years of age ASA (American society of Anesthesiologists) I-III Exclusion Criteria: * Pediatric age group * ASA more than III
Where this trial is running
Giza
- Research Institute of Ophthalmolgy — Giza, Egypt (Recruiting)
Study contacts
- Study coordinator: Dina Moustafa Mohamed Ali, MD
- Email: dina.moustafa.ali@gmail.com
- Phone: 01113981021
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.